Core Scientific (NASDAQ:CORZ) Posts Quarterly Earnings Results, Misses Expectations By $1.04 EPS

08 May 2026, 13:36 by Renee Jackson · The Cerbat Gem

Core Scientific (NASDAQ:CORZ – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($1.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($1.04), FiscalAI reports. The business had revenue of $115.24 million during the quarter, compared to analyst estimates of $117.04 million. During the same quarter in the previous year, the business posted $1.25 EPS. Core Scientific’s revenue for the quarter was up 44.9% on a year-over-year basis.

Here are the key takeaways from Core Scientific’s conference call:

Closed a $3.3 billion CoreWeave project bond at 7.75% (net proceeds ~$2.9 billion) with a lockbox structure, enabling corporate‑level deployment of proceeds and supporting roughly $2 billion of planned 2026 capex.
Billing 243 MW today (≈$350M annualized GAAP colocation revenue), expects >450 MW by end of summer and the full 590 MW by early 2027, and raised CoreWeave cash gross profit target to 80–85%.
Accelerating development by investing ahead of leases—securing land, labor and long‑lead equipment to hit 12–14 month RFS targets and pursue campus growth (Pecos and Muskogee paths to ~1.5 GW each).
Pursuing behind‑the‑meter and natural gas options (lead time ~12–14 months) with a mix of ownership and PPAs and active permitting efforts, which enables expansion but adds regulatory and execution complexity.
Bitcoin mining will continue winding down through the year (only one or two sites expected running by year‑end) after monetizing most holdings, shifting the business mix toward colocation.

Core Scientific Stock Up 2.0%

Shares of CORZ stock traded up $0.45 on Friday, hitting $22.81. The stock had a trading volume of 6,709,015 shares, compared to its average volume of 12,708,490. Core Scientific has a one year low of $9.17 and a one year high of $25.01. The business has a 50 day moving average price of $17.75 and a 200 day moving average price of $17.49. The company has a market cap of $7.20 billion, a PE ratio of -19.99 and a beta of 5.45.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CORZ shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Core Scientific in a research note on Monday, April 20th. LADENBURG THALM/SH SH dropped their target price on Core Scientific from $24.50 to $23.75 and set a “buy” rating for the company in a research report on Tuesday, March 3rd. Cantor Fitzgerald raised their price target on Core Scientific from $25.00 to $29.00 and gave the stock an “overweight” rating in a research note on Thursday, April 9th. Keefe, Bruyette & Woods boosted their price objective on Core Scientific from $19.00 to $25.00 and gave the company a “moderate buy” rating in a report on Tuesday, January 27th. Finally, Wall Street Zen raised Core Scientific to a “sell” rating in a research report on Saturday, March 14th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Core Scientific presently has an average rating of “Moderate Buy” and a consensus price target of $26.01.

Check Out Our Latest Stock Report on CORZ

Insider Buying and Selling at Core Scientific

In other news, insider Todd M. Duchene sold 10,000 shares of the stock in a transaction that occurred on Monday, May 4th. The shares were sold at an average price of $20.86, for a total transaction of $208,600.00. Following the transaction, the insider directly owned 1,980,348 shares in the company, valued at approximately $41,310,059.28. This trade represents a 0.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Over the last three months, insiders have sold 50,000 shares of company stock valued at $933,400. 1.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Core Scientific

A number of institutional investors have recently added to or reduced their stakes in CORZ. Value Aligned Research Advisors LLC bought a new position in Core Scientific in the fourth quarter worth about $117,786,000. Situational Awareness LP boosted its holdings in shares of Core Scientific by 76.8% in the 2nd quarter. Situational Awareness LP now owns 7,994,038 shares of the company’s stock valued at $136,458,000 after buying an additional 3,472,460 shares in the last quarter. State Street Corp grew its position in shares of Core Scientific by 3.3% in the 4th quarter. State Street Corp now owns 7,156,301 shares of the company’s stock worth $104,196,000 after buying an additional 230,048 shares during the last quarter. Helix Partners Management LP grew its position in shares of Core Scientific by 6.7% in the 4th quarter. Helix Partners Management LP now owns 5,600,000 shares of the company’s stock worth $81,536,000 after buying an additional 350,000 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Core Scientific by 584.2% during the fourth quarter. JPMorgan Chase & Co. now owns 3,689,053 shares of the company’s stock worth $53,713,000 after purchasing an additional 3,149,859 shares in the last quarter.

Core Scientific Company Profile

(Get Free Report)

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.